Podcast appearances and mentions of Jonathan H Marks

Jonathan H. Marks argues that public-private partnerships create “webs of influence” that undermine the integrity of public health agencies and distort health policy and research. These collaborations also frame public health problems and their solutions in ways that protect and promote the commercial interests of corporate “partners.” We should expect multinational corporations to develop strategies of influence as far as the law allows. But public bodies can and should develop counter-strategies to insulate themselves from influence.

Art organizations and sponsorship dollars have gone hand in hand for decades. But with backlash and protests over donors ethics, should cultural institutions begin looking into new funding streams? We look at the role of private dollars vs. public good in cultural art institutions. PLUS, A AUDIO EXCLUSIVE: The conversation continues with guest Jonathan H. Marks We discuss his new book “Perils of Partnership.” Music Featured: Reverend Billy & The Stop Shopping Choir, a radical activist performance community, with “Beatitudes”, from their premiere album “The Shopocalypse.” Guests: L.A. Kauffman, activist and member of Sackler P.A.I.N and Author, HOW TO READ A PROTEST Professor Jonathan H. Marks Director of the Bioethics Program at Penn State University, and affiliate faculty in law and international affairs. And author of a new book “Perils of Partnership” Jess Worth, Activist, co-founder of “BP or not BP”and the Art Not Oil coalitions and currently is the co-director of Culture Unstained. For suggested reading, research and links to our guests and issues featured in this episode, go to: Patreon.com/theLFShow

It is an article of faith in many circles that the most effective and efficient way to solve a broad range of local and national problems is through public-private partnerships. What's not to like? Especially in a climate in which people think resources are scarce, seeking out help from corporate actors seems an obvious win-win. But it's not. Listen to Jonathan H. Marks discuss The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health (Oxford University Press, 2019), and the public harm and private profiteering that are too often the result of these relationships. Stephen Pimpare is Senior Lecturer in the Politics & Society Program and Faculty Fellow at the Carsey School of Public Policy at the University of New Hampshire. He is the author of The New Victorians (New Press, 2004), A People's History of Poverty in America (New Press, 2008), winner of the Michael Harrington Award, and Ghettos, Tramps and Welfare Queens: Down and Out on the Silver Screen (Oxford, 2017). Learn more about your ad choices. Visit megaphone.fm/adchoices

It is an article of faith in many circles that the most effective and efficient way to solve a broad range of local and national problems is through public-private partnerships. What’s not to like? Especially in a climate in which people think resources are scarce, seeking out help from corporate actors seems an obvious win-win. But it’s not. Listen to Jonathan H. Marks discuss The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health (Oxford University Press, 2019), and the public harm and private profiteering that are too often the result of these relationships. Stephen Pimpare is Senior Lecturer in the Politics & Society Program and Faculty Fellow at the Carsey School of Public Policy at the University of New Hampshire. He is the author of The New Victorians (New Press, 2004), A People’s History of Poverty in America (New Press, 2008), winner of the Michael Harrington Award, and Ghettos, Tramps and Welfare Queens: Down and Out on the Silver Screen (Oxford, 2017). Learn more about your ad choices. Visit megaphone.fm/adchoices

It is an article of faith in many circles that the most effective and efficient way to solve a broad range of local and national problems is through public-private partnerships. What’s not to like? Especially in a climate in which people think resources are scarce, seeking out help from corporate actors seems an obvious win-win. But it’s not. Listen to Jonathan H. Marks discuss The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health (Oxford University Press, 2019), and the public harm and private profiteering that are too often the result of these relationships. Stephen Pimpare is Senior Lecturer in the Politics & Society Program and Faculty Fellow at the Carsey School of Public Policy at the University of New Hampshire. He is the author of The New Victorians (New Press, 2004), A People’s History of Poverty in America (New Press, 2008), winner of the Michael Harrington Award, and Ghettos, Tramps and Welfare Queens: Down and Out on the Silver Screen (Oxford, 2017). Learn more about your ad choices. Visit megaphone.fm/adchoices

It is an article of faith in many circles that the most effective and efficient way to solve a broad range of local and national problems is through public-private partnerships. What’s not to like? Especially in a climate in which people think resources are scarce, seeking out help from corporate actors seems an obvious win-win. But it’s not. Listen to Jonathan H. Marks discuss The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health (Oxford University Press, 2019), and the public harm and private profiteering that are too often the result of these relationships. Stephen Pimpare is Senior Lecturer in the Politics & Society Program and Faculty Fellow at the Carsey School of Public Policy at the University of New Hampshire. He is the author of The New Victorians (New Press, 2004), A People’s History of Poverty in America (New Press, 2008), winner of the Michael Harrington Award, and Ghettos, Tramps and Welfare Queens: Down and Out on the Silver Screen (Oxford, 2017). Learn more about your ad choices. Visit megaphone.fm/adchoices

It is an article of faith in many circles that the most effective and efficient way to solve a broad range of local and national problems is through public-private partnerships. What’s not to like? Especially in a climate in which people think resources are scarce, seeking out help from corporate actors seems an obvious win-win. But it’s not. Listen to Jonathan H. Marks discuss The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health (Oxford University Press, 2019), and the public harm and private profiteering that are too often the result of these relationships. Stephen Pimpare is Senior Lecturer in the Politics & Society Program and Faculty Fellow at the Carsey School of Public Policy at the University of New Hampshire. He is the author of The New Victorians (New Press, 2004), A People’s History of Poverty in America (New Press, 2008), winner of the Michael Harrington Award, and Ghettos, Tramps and Welfare Queens: Down and Out on the Silver Screen (Oxford, 2017). Learn more about your ad choices. Visit megaphone.fm/adchoices

It is an article of faith in many circles that the most effective and efficient way to solve a broad range of local and national problems is through public-private partnerships. What's not to like? Especially in a climate in which people think resources are scarce, seeking out help from corporate actors seems an obvious win-win. But it's not. Listen to Jonathan H. Marks discuss The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health (Oxford University Press, 2019), and the public harm and private profiteering that are too often the result of these relationships. Stephen Pimpare is Senior Lecturer in the Politics & Society Program and Faculty Fellow at the Carsey School of Public Policy at the University of New Hampshire. He is the author of The New Victorians (New Press, 2004), A People's History of Poverty in America (New Press, 2008), winner of the Michael Harrington Award, and Ghettos, Tramps and Welfare Queens: Down and Out on the Silver Screen (Oxford, 2017).

My guest is Jonathan H. Marks. His new book is The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health (https://www.amazon.com/Perils-Partnership-Influence-Institutional-Integrity/dp/0190907088/ref=tmm_hrd_swatch_0?_encoding=UTF8&qid=&sr=). Countless public health agencies are trying to solve our most intractable public health problems -- among them, the obesity and opioid epidemics -- by partnering with corporations responsible for creating or exacerbating those problems. We are told industry must be part of the solution. But is it time to challenge the partnership paradigm and the popular narratives that sustain it? In The Perils of Partnership, (https://www.amazon.com/Perils-Partnership-Influence-Institutional-Integrity/dp/0190907088/ref=tmm_hrd_swatch_0?_encoding=UTF8&qid=&sr=) Jonathan H. Marks argues that public-private partnerships and multi-stakeholder initiatives create "webs of influence" that undermine the integrity of public health agencies; distort public health research and policy; and reinforce the framing of public health problems and their solutions in ways that are least threatening to the commercial interests of corporate "partners". We should expect multinational corporations to develop strategies of influence -- but public bodies can and should develop counter-strategies to insulate themselves from corporate influence in all its forms. Marks reviews the norms that regulate public-public interactions (separation of powers) and private-private interactions (antitrust and competition law), and argues for an analogous set of norms to govern public-private interactions. He also offers a novel framework to help public bodies identify the systemic ethical implications of their current or proposed relationships with industry actors. Marks makes a compelling case that the default public-private interaction should be at arm's length: separation, not collaboration. He calls for a new paradigm that avoids the perils of corporate influence and more effectively protects and promotes public health. The Perils of Partnership is essential reading for public health officials and policymakers -- but anyone interested in public health will recognize the urgency of this book. Special Guest: Jonathan H. Marks.

Jonathan H. Marks is director of the Bioethics Program at Penn State University, and affiliate faculty at Penn State Law and International Affairs. He is also a barrister and academic member of Matrix Chambers, London and Geneva.   CONNECT with Jonathan HERE LISTEN to Jonathan's TEDx talk HERE CHECK OUT Jonathan's Book HERE FOLLOW Jonathan on Twitter HERE BeTheTalk is a podcast where Nathan Eckel chats with talkers from TEDx & branded events. Tips tools and techniques that can help you give the talk to change the world at BeTheTalk.com !

Jonathan H. Marks is director of the Bioethics Program at Penn State University, and affiliate faculty at Penn State Law and International Affairs. He is also a barrister and academic member of Matrix Chambers, London and Geneva.   CONNECT with Jonathan HERE LISTEN to Jonathan's TEDx talk HERE CHECK OUT Jonathan's Book HERE FOLLOW Jonathan on Twitter HERE BeTheTalk is a podcast where Nathan Eckel chats with talkers from TEDx & branded events. Tips tools and techniques that can help you give the talk to change the world at BeTheTalk.com !

According to the CDC, between 1999 and 2017 over 218,000 Americans died due to overdoses from prescription opioids--more than 3 times the number of Americans killed in Vietnam. A current Massachusetts court case alleges that Purdue Pharmaceuticals, the multi-billion dollar company that makes Oxycontin, continued to “turbocharge” sales of the drug while downplaying its extreme danger--for more than a decade after pleading guilty in 2007 to misleading regulators, doctors, and patients about the drug’s risk of addiction and potential for abuse. And yet in 2017, when the National Institutes of Health held meetings to combat the crisis, they turned to…Purdue executives for advice. This would be darkly comic if so many lives were not at stake—and the practice was not so common. Building on the ideas in his popular TED talk “In Praise of Conflict,” Jonathan H. Marks examines the widespread practice of public-private partnerships in “The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health.” Join us on “Leonard Lopate at Large” on WBAI for a conversation with Jonathan H. Marks about why this troubling practice needs to stop.

What are the effects of industry (for example, pharmaceutical, petroleum, or food industries) when they sponsor specific research programs? Dr. Marks, Associate Professor of Bioethics, Humanities, and Law at Penn State University tackles this challenging question by showing how results of industry-sponsored research are favorably correlated with results that suit the interests of the sponsors. Although the mechanisms that produce this correlation are not entirely known (i.e. systemic biases, funding effects, etc.), Dr. Marks unveils a broader picture in order to highlight the ethical challenges raised by this research practice. His interest lies in the ways in which industry/academic collaborations not only favor commercializable results, but also shape the kind of questions that ought to be asked and how they ought to be answered. Who is Jonathan Marks? Jonathan H. Marks is currently a non-residential fellow at the Edmond J. Safra Center for Ethics at Harvard University. He leads a collaborative research project that is jointly funded by the Rock Ethics Institute and the Edmond J. Safra Center for Ethics (through its Lab on Institutional Corruption), exploring the ethical and policy implications of industry sponsorship of health-related food research, nutrition education, and practice. Marks has co-organized—with Donald B. Thompson, emeritus professor of food science at Penn State—a workshop sponsored by the Rock Ethics Institute on “The Ethical Challenges and Policy Implications of Industry-Funded Health-Related Food Research” (Penn State, March 2008), a follow-up symposium entitled “Industry Sponsorship and Health-Related Food Research Institutional Integrity, Ethical Challenges, and Policy Implications” (Penn State, March 2012); and the Rock Ethics Institute’s Food Ethics Lecture Series 2011–12. Marks took the lead role in developing Penn State’s new dual-title Ph.D. program in bioethics (the first of its kind in the country) that allows and requires students to combine bioethics with one of a number of other disciplines in their dissertation. Marks has published widely on the intersections of law, ethics, human rights, and policy, and his work has appeared in the New England Journal of Medicine, American Journal of Law and Medicine, American Journal of Bioethics, and the Hastings Center Report (among others). He has also authored or co-authored op-eds for the New York Times, Los Angeles Times and The Times (London) (among others). In addition to his work on food ethics, he writes about, teaches courses, and has co-organized an international conference on neuroethics and neurolaw. He has also written extensively about the role of health professionals in detention and interrogation in the “war on terror”—part of an ongoing larger project that explores the relationship between professional ethics and human rights. Jonathan Marks spent 2009–2011 in residence at the Edmond J. Safra Center for Ethics at Harvard, and prior to joining Penn State, was a Greenwall Fellow in Bioethics at Georgetown and Johns Hopkins Universities. Marks is also a barrister and academic member of Matrix Chambers, London. While in full time legal practice, he was involved in a number of landmark cases including the Pinochet case and the Olivieri case—the latter arising from a dispute between a physician-researcher and the drug company sponsor of her clinical trials.

We rely on universities to conduct research that seeks to explore and address society’s most complex and pressing problems—from obesity and cancer to energy and climate change. However, universities rely increasingly on money from industry to fund scientific research. Sometimes industry support comes in the form of research grants; at other times, in the form of corporate philanthropy. Critics often express concern about individual financial conflicts of interest, pointing to several studies that find a correlation between industry funding of research and results that are more favorable to industry sponsors. However, far less attention has been paid to the broader systemic effects of industry funding on research universities and on scientific research. This lecture will explore these broader systemic effects, and examine the ethical implications of academy-industry relations, with a focus on institutional integrity; scientific integrity; and trust and confidence in scientists, their institutions, and the products of their research. Jonathan H. Marks is currently a non-residential fellow at theJonathan H. Marks Edmond J. Safra Center for Ethics at Harvard University. He leads a collaborative research project that is jointly funded by the Rock Ethics Institute and the Edmond J. Safra Center for Ethics (through its Lab on Institutional Corruption), exploring the ethical and policy implications of industry sponsorship of health-related food research, nutrition education, and practice. Marks has co-organized—with Donald B. Thompson, emeritus professor of food science at Penn State—a workshop sponsored by the Rock Ethics Institute on “The Ethical Challenges and Policy Implications of Industry-Funded Health-Related Food Research” (Penn State, March 2008), a follow-up symposium entitled “Industry Sponsorship and Health-Related Food Research Institutional Integrity, Ethical Challenges, and Policy Implications” (Penn State, March 2012); and the Rock Ethics Institute’s Food Ethics Lecture Series 2011–12. Marks took the lead role in developing Penn State’s new dual-title Ph.D. program in bioethics (the first of its kind in the country) that allows and requires students to combine bioethics with one of a number of other disciplines in their dissertation. Marks has published widely on the intersections of law, ethics, human rights, and policy, and his work has appeared in the New England Journal of Medicine, American Journal of Law and Medicine, American Journal of Bioethics, and the Hastings Center Report (among others). He has also authored or co-authored op-eds for the New York Times, Los Angeles Times and The Times (London) (among others). In addition to his work on food ethics, he writes about, teaches courses, and has co-organized an international conference on neuroethics and neurolaw. He has also written extensively about the role of health professionals in detention and interrogation in the “war on terror”—part of an ongoing larger project that explores the relationship between professional ethics and human rights. Jonathan Marks spent 2009–2011 in residence at the Edmond J. Safra Center for Ethics at Harvard, and prior to joining Penn State, was a Greenwall Fellow in Bioethics at Georgetown and Johns Hopkins Universities. Marks is also a barrister and academic member of Matrix Chambers, London. While in full time legal practice, he was involved in a number of landmark cases including the Pinochet case and the Olivieri case—the latter arising from a dispute between a physician-researcher and the drug company sponsor of her clinical trials.

We rely on universities to conduct research that seeks to explore and address society’s most complex and pressing problems—from obesity and cancer to energy and climate change. However, universities rely increasingly on money from industry to fund scientific research. Sometimes industry support comes in the form of research grants; at other times, in the form of corporate philanthropy. Critics often express concern about individual financial conflicts of interest, pointing to several studies that find a correlation between industry funding of research and results that are more favorable to industry sponsors. However, far less attention has been paid to the broader systemic effects of industry funding on research universities and on scientific research. This lecture will explore these broader systemic effects, and examine the ethical implications of academy-industry relations, with a focus on institutional integrity; scientific integrity; and trust and confidence in scientists, their institutions, and the products of their research. Jonathan H. Marks is currently a non-residential fellow at theJonathan H. Marks Edmond J. Safra Center for Ethics at Harvard University. He leads a collaborative research project that is jointly funded by the Rock Ethics Institute and the Edmond J. Safra Center for Ethics (through its Lab on Institutional Corruption), exploring the ethical and policy implications of industry sponsorship of health-related food research, nutrition education, and practice. Marks has co-organized—with Donald B. Thompson, emeritus professor of food science at Penn State—a workshop sponsored by the Rock Ethics Institute on “The Ethical Challenges and Policy Implications of Industry-Funded Health-Related Food Research” (Penn State, March 2008), a follow-up symposium entitled “Industry Sponsorship and Health-Related Food Research Institutional Integrity, Ethical Challenges, and Policy Implications” (Penn State, March 2012); and the Rock Ethics Institute’s Food Ethics Lecture Series 2011–12. Marks took the lead role in developing Penn State’s new dual-title Ph.D. program in bioethics (the first of its kind in the country) that allows and requires students to combine bioethics with one of a number of other disciplines in their dissertation. Marks has published widely on the intersections of law, ethics, human rights, and policy, and his work has appeared in the New England Journal of Medicine, American Journal of Law and Medicine, American Journal of Bioethics, and the Hastings Center Report (among others). He has also authored or co-authored op-eds for the New York Times, Los Angeles Times and The Times (London) (among others). In addition to his work on food ethics, he writes about, teaches courses, and has co-organized an international conference on neuroethics and neurolaw. He has also written extensively about the role of health professionals in detention and interrogation in the “war on terror”—part of an ongoing larger project that explores the relationship between professional ethics and human rights. Jonathan Marks spent 2009–2011 in residence at the Edmond J. Safra Center for Ethics at Harvard, and prior to joining Penn State, was a Greenwall Fellow in Bioethics at Georgetown and Johns Hopkins Universities. Marks is also a barrister and academic member of Matrix Chambers, London. While in full time legal practice, he was involved in a number of landmark cases including the Pinochet case and the Olivieri case—the latter arising from a dispute between a physician-researcher and the drug company sponsor of her clinical trials.

We rely on universities to conduct research that seeks to explore and address society’s most complex and pressing problems—from obesity and cancer to energy and climate change. However, universities rely increasingly on money from industry to fund scientific research. Sometimes industry support comes in the form of research grants; at other times, in the form of corporate philanthropy. Critics often express concern about individual financial conflicts of interest, pointing to several studies that find a correlation between industry funding of research and results that are more favorable to industry sponsors. However, far less attention has been paid to the broader systemic effects of industry funding on research universities and on scientific research. This lecture will explore these broader systemic effects, and examine the ethical implications of academy-industry relations, with a focus on institutional integrity; scientific integrity; and trust and confidence in scientists, their institutions, and the products of their research. Jonathan H. Marks is currently a non-residential fellow at theEdmond J. Safra Center for Ethics at Harvard University. He leads a collaborative research project that is jointly funded by the Rock Ethics Institute and the Edmond J. Safra Center for Ethics (through its Lab on Institutional Corruption), exploring the ethical and policy implications of industry sponsorship of health-related food research, nutrition education, and practice. Marks has co-organized—with Donald B. Thompson, emeritus professor of food science at Penn State—a workshop sponsored by the Rock Ethics Institute on “The Ethical Challenges and Policy Implications of Industry-Funded Health-Related Food Research” (Penn State, March 2008), a follow-up symposium entitled “Industry Sponsorship and Health-Related Food Research Institutional Integrity, Ethical Challenges, and Policy Implications” (Penn State, March 2012); and the Rock Ethics Institute’s Food Ethics Lecture Series 2011–12. Marks took the lead role in developing Penn State’s new dual-title Ph.D. program in bioethics (the first of its kind in the country) that allows and requires students to combine bioethics with one of a number of other disciplines in their dissertation. Marks has published widely on the intersections of law, ethics, human rights, and policy, and his work has appeared in the New England Journal of Medicine, American Journal of Law and Medicine, American Journal of Bioethics, and the Hastings Center Report (among others). He has also authored or co-authored op-eds for the New York Times, Los Angeles Times and The Times (London) (among others). In addition to his work on food ethics, he writes about, teaches courses, and has co-organized an international conference on neuroethics and neurolaw. He has also written extensively about the role of health professionals in detention and interrogation in the “war on terror”—part of an ongoing larger project that explores the relationship between professional ethics and human rights. Jonathan Marks spent 2009–2011 in residence at the Edmond J. Safra Center for Ethics at Harvard, and prior to joining Penn State, was a Greenwall Fellow in Bioethics at Georgetown and Johns Hopkins Universities. Marks is also a barrister and academic member of Matrix Chambers, London. While in full time legal practice, he was involved in a number of landmark cases including the Pinochet case and the Olivieri case—the latter arising from a dispute between a physician-researcher and the drug company sponsor of her clinical trials.